These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 4080767

  • 1. Phencyclidine-induced dopamine-dependent behaviors in chronic haloperidol-treated rats.
    Yamaguchi K, Nabeshima T, Amano M, Yoshida S, Furukawa H, Kameyama T.
    Pharmacol Biochem Behav; 1985 Nov; 23(5):803-9. PubMed ID: 4080767
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors.
    Yamaguchi K, Nabeshima T, Kameyama T.
    J Pharmacobiodyn; 1986 May; 9(5):479-89. PubMed ID: 2945001
    [Abstract] [Full Text] [Related]

  • 3. Role of dopaminergic and serotonergic neuronal systems in the prefrontal cortex of rats in phencyclidine-induced behaviors.
    Yamaguchi K, Nabeshima T, Kameyama T.
    J Pharmacobiodyn; 1986 Dec; 9(12):987-96. PubMed ID: 3572718
    [Abstract] [Full Text] [Related]

  • 4. Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior.
    Yamaguchi K, Nabeshima T, Kameyama T.
    J Pharmacobiodyn; 1986 Dec; 9(12):975-86. PubMed ID: 3033192
    [Abstract] [Full Text] [Related]

  • 5. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
    Kitaichi K, Yamada K, Hasegawa T, Furukawa H, Nabeshima T.
    Jpn J Pharmacol; 1994 Oct; 66(2):181-9. PubMed ID: 7532732
    [Abstract] [Full Text] [Related]

  • 6. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
    Nabeshima T, Yamaguchi K, Ishikawa K, Furukawa H, Kameyama T.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
    [Abstract] [Full Text] [Related]

  • 7. Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine.
    Nabeshima T, Fukaya H, Yamaguchi K, Ishikawa K, Furukawa H, Kameyama T.
    Eur J Pharmacol; 1987 Mar 03; 135(1):23-33. PubMed ID: 3569423
    [Abstract] [Full Text] [Related]

  • 8. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study.
    Steinpreis RE, Salamone JD.
    Brain Res; 1993 May 28; 612(1-2):263-70. PubMed ID: 8330204
    [Abstract] [Full Text] [Related]

  • 9. Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum.
    Nabeshima T, Yamaguchi K, Yamada K, Hiramatsu M, Furukawa H, Kameyama T.
    Eur J Pharmacol; 1983 Sep 30; 93(3-4):229-34. PubMed ID: 6416871
    [Abstract] [Full Text] [Related]

  • 10. Involvement of dopamine D1 receptors in phencyclidine-induced behavioral stimulation in rats.
    Tsutsumi T, Hirano M, Matsumoto T, Nakamura K, Hashimoto K, Hondo H, Yonezawa Y, Tsukashima A, Nakane H, Uchimura H.
    Clin Neuropharmacol; 1995 Feb 30; 18(1):64-71. PubMed ID: 8665536
    [Abstract] [Full Text] [Related]

  • 11. Drug-induced circling preference in rats. Correlation with monoamine levels.
    Ali SF, Kordsmeier KJ, Gough B.
    Mol Neurobiol; 1995 Feb 30; 11(1-3):145-54. PubMed ID: 8561958
    [Abstract] [Full Text] [Related]

  • 12. Phencyclidine-induced stereotype in rats: effects of methadone, apomorphine, and naloxone.
    Verebey K, Kogan MJ, Mulè SJ.
    Psychopharmacology (Berl); 1981 Feb 30; 75(1):44-7. PubMed ID: 6795658
    [Abstract] [Full Text] [Related]

  • 13. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun 30; 15(3):247-52. PubMed ID: 7584718
    [Abstract] [Full Text] [Related]

  • 14. Serotonergic involvement in phencyclidine-induced behaviors.
    Nabeshima T, Yamaguchi K, Hiramatsu M, Amano M, Furukawa H, Kameyama T.
    Pharmacol Biochem Behav; 1984 Sep 30; 21(3):401-8. PubMed ID: 6208563
    [Abstract] [Full Text] [Related]

  • 15. Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine.
    Johnson KM.
    Fed Proc; 1983 Jun 30; 42(9):2579-83. PubMed ID: 6133782
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
    Hiramatsu M, Cho AK, Nabeshima T.
    Eur J Pharmacol; 1989 Aug 03; 166(3):359-66. PubMed ID: 2553433
    [Abstract] [Full Text] [Related]

  • 17. Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats.
    Suemaru K, Gomita Y, Furuno K, Araki Y.
    Pharmacol Biochem Behav; 1993 Sep 03; 46(1):135-9. PubMed ID: 7902980
    [Abstract] [Full Text] [Related]

  • 18. Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine.
    Kitaichi K, Yamada K, Yoneda Y, Ogita K, Hasegawa T, Furukawa H, Nabeshima T.
    Life Sci; 1995 Sep 03; 56(7):531-43. PubMed ID: 7532775
    [Abstract] [Full Text] [Related]

  • 19. Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
    Abekawa T, Honda M, Ito K, Koyama T.
    Psychopharmacology (Berl); 2003 Sep 03; 169(3-4):247-56. PubMed ID: 12898123
    [Abstract] [Full Text] [Related]

  • 20. Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats.
    Nabeshima T, Yamada K, Yamaguchi K, Hiramatsu M, Furukawa H, Kameyama T.
    Eur J Pharmacol; 1983 Aug 05; 91(4):455-62. PubMed ID: 6684578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.